NCT Number: NCT00877981
Open Versus Video-Assisted Minimal-Invasive Parathyroid Surgery
The aim of the present study was to compare open minimal-invasive parathyroid surgery with video-assisted parathyroidectomy in primary hyperparathyroidism (PHPT) patients with a positive sestamibi scan in a multicentre randomized trial in order to evaluate if videoassisted surgery gave less postoperative pain and if there was a difference in operating time.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Unit of Breast and Endocrine Surgery, Surgical Department P, Aarhus University Hospital, Aarhus, Denmark
About this study
The present study is designed to compare open minimal-invasive parathyroid surgery with video-assisted parathyroidectomy in pHPT patients with a positive sestamibi scan in a multicentre prospective randomized trial.
In patients randomized to open surgery, a 15 mm transverse skin incision is made close to the site of the parathyroid adenoma indicated by sestamibi scintigraphy. In case of an enlarged upper parathyroid or dorsally located lower parathyroid, the incision is made anterior to the sternocleidomastoid muscle (SCM) whereas for anterior located lower parathyroids a central incision is chosen.
In patients randomized to a video-assisted approach, the surgeon has the option to choose either the lateral- (VAPLA) or medial (MIVAP) techniques, both initiated with a 15 mm transverse skin incision.
Postoperatively the patients receive a questionnaire for selfdocumentation.Variables recorded include postoperative pain, hypocalcaemic symptoms, breathing problems, cervical discomforts of pressure/globus and voice disturbances. A visual analogue scale (VAS) is used when appropriate. The intake of oral analgesics and calcium medication is also recorded. The questionnaire is used daily for the first four postoperative days, and thereafter weekly for four weeks.
Follow-up is done at 1 and 6 month after surgery, with measurement of plasma calcium and PTH. Continued needs of calcium or vitamin D medication, length of scar, and symptoms or signs of complications are recorded. At the six-month follow-up, patients document their opinion of the cosmetic results and the remaining neck discomfort using a VAS.
Primary outcome measures are postoperative pain and operation time. Secondary outcome measures are complications, persistent or recurrent disease, conversion rates and cosmetic results.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Patients with biochemically verified primary hyperparathyroidism and with an unequivocal localisation on sestamibi scintigraphy of a solitary parathyroid adenoma
Exclusion criteria
- Negative or equivocal preoperative localization study, familiar HPT, previous neck surgery or neck irradiation, concomitant need of thyroid surgery, pregnancy, suspected ectopic parathyroid localization, or inability to understand information, instructions and/or comply with scheduled follow-up.
Treatment and study plan
Primary outcomes
-
Postoperative pain
Time frame: 4 days
-
Operating time
Secondary outcomes
-
complications
Time frame: 6 months
-
Persistent or recurrent disease
Time frame: 6 months
-
conversion rate
-
Cosmetic results
Sponsors and collaborators
Lead sponsor
Uppsala University
Other
Collaborators
- Lund University
- University of Aarhus
Registry information
Official study title
Open Compared to Video-Assisted Minimal-Invasive Parathyroid Surgery in Primary Hyperparathyroidism
Important dates
- Study start
- 2003
- Primary completion
- 2007
- Study completion
- 2007
- First posted
- Apr 8, 2009
- Registry last updated
- Apr 8, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Upfront Ultrasound for Preoperative Localization in Primary Hyperparathyroidism
NCT07068867
Endocrine System Diseases, Hyperparathyroidism
Odense, Denmark
View Trial DetailsThe Midwest Head and Neck Cancer Consortium Multi-Institutional Parathyroid Registry
NCT01409798
Calcium Metabolism Disorders, Endocrine System Diseases
Iowa City, Iowa, United States
View Trial DetailsNatural History Study of Parathyroid Disorders
NCT04969926
Bone Diseases, Bone Diseases, Metabolic
Bethesda, Maryland, United States
View Trial DetailsGlycemic Control, Type II Diabetes, Parathyroidectomy
NCT05761743
Diabetes Mellitus, Diabetes Mellitus, Type 2
Cleveland, Ohio, United States
View Trial Details